You have read all your free articles, to continue reading subscribe to read the rest of this content.
Beactica Therapeutics and Oscotec, a Korean drug development company, have announced a new research development and licensing agreement. The two companies will initially jointly collaborate concerning research and early preclinical development of novel anticancer drug candidates arising out of BeAlready a subscriber Login You have read all your free articles,…
The company's antibiotic-eluting product CERAMENT G has been approved by Health Canada. CERAMENT G is a CE-marked gentamicin-eluting injectable ceramic bone graft substitute on the market. CERAMENT G sales have been growing strongly based on the clinical benefits it delivers when used for indicAlready a subscriber Login You have read…
UmanDiagnostics has signed a new licensing and supply agreement with global giant Siemens. “Siemens is a world leader in our industry, so this is an extremely important agreement for us,” says Niklas Norgren, CEO of UmanDiagnostics. Acquired by Quanterix This summer UmanDiagnostics was purcAlready a subscriber Login You have read…
As Swedish clinicians treating large numbers of asthma patients, Henrik Ljungberg and Björn Nordlund often spent time reviewing the multiple prescriptions and directives patients received from different providers after flare-ups. “Often when an asthma patient is not doing well, their doctor oAlready a subscriber Login You have read all your free…
